Principal

Rob Woodman joined Sofinnova in January 2007 as an analyst in the life sciences team. Prior to Sofinnova, from 2005 – 2006, Rob worked in the Business Management team at Cancer Research Technology Ltd, an oncology focused technology transfer and development company in the UK, and in 2004 was a Business Analyst in the Management Consultancy Group of pharmaceutical information source IMS Health, also in the UK. Rob holds a PhD in Molecular and Cellular Biology / Oncology from the University of Cambridge and an MSc in Biochemistry from the University of Oxford.  Inventions made during the course of Rob’s PhD were patented, and the patent has been licensed to big pharma.  His research was also published in peer reviewed journals.